NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

The current Advent rate card for compassionate use was created in 2021.
"COST FOR MANUFACTURING 6 DOSES FOR YEAR 1 OF TREATMENTTotal of £150,000(in 2 stages) to cover the one-time upfront manufacturing of the personalised ADCV and 6 doses for Year 1 of treatment. The invoices are sent by Advent Bioservices and all payments must be made in advance." 1 pound is worth US$1.23 means 150,000 UK pounds is US$184.000
https://pdfhost.io/v/uefyY7bO0_Advent

Sawston was previously approved for manufacturing for clinical trials and compassionate use, but not commercial use.

You can see from NWBO's revenue that not many patients are participation in compassionate use, very likely because of the HIGH cost and no payer coverage.

NWBO's rGBM treatment are had NO resections -- was not part of the protocol -- look it up.
Neuro-ocology is a small tight knit community and read clinical data. They have seen JAMA Oncology and have also read the three neuro-oncology comments and three other publications that all challenge the legitimacy of the conclusions. So have seen all of the data and only a handful are being referred to compassionate use annually as they have seen the data.